ArticleCancer chemotherapy and pharmacology2024

Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy.

Hongjie Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.